glp 1 agonist and heart failure Impact of GLP-1 receptor agonists on cardiovascular outcomes in with preserved ejection fraction (HFpEF): systematic review meta-analysis | Clinical Research in Cardiology Glucagon-Like Peptide 1 Receptor Agonists

The fusion between autophagosomes and lysosomes is driven by the coordinated action of two distinct soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes (STX17-SNAP29-VAMP8 and YKT6-SNAP29-STX7), tethering factors (e.g., the HOPS complex) and Ras-associated binding proteins (RABs) (e.g., Rab7) (81, 8689) ( Figure 1 , panel 4)

Reduction of intracellular GSH alone did not activate the ISR and cystine starvation induced a robust ISR which was not aggravated by BSO treatment (Fig

A.YalcinC

GLP-1 exerts its effects through the GLP-1 receptor, which is found in various tissues, including the brain, pancreas, stomach, heart, kidneys, and adipose tissue [14, 15]